ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Evaluation of Conventional Histopathological Scoring in Breast Carcinoma Using Artificial Intelligence Technologies

Seda Çetinkaya Karabekir, Aylin Gökhan, Hilal Arslan, Burak Keskin, Adile Ferda Dağlı.



Abstract
Download PDF Post

Aim: Breast cancer is the most frequently diagnosed malignancy among women worldwide, and early detection plays a critical role in the success of treatment. The Ki 67 proliferation index is widely used to evaluate tumor cell proliferation; however, its manual scoring process is observer-dependent, time-consuming, and inherently subjective. This study aims to assess Ki 67 immunohistochemical staining using deep learning algorithms in an objective, rapid, and reproducible manner, and to compare the model’s performance with conventional scoring methods.
Materials and Methods: In the first phase of the study, a dataset was created using digital images of Ki-67-stained histological sections obtained from patients diagnosed with breast cancer. These images were used to train a machine learning algorithm. In the second phase, 50 new Ki-67-stained tissue sections previously unseen by the model were digitized, and the model’s predictions were compared with Ki 67 index values calculated by conventional manual assessment.
Results: The developed model achieved a mean absolute error (MAE) of 8.69%, a root mean square error (RMSE) of 13.00%, and a coefficient of determination (R²) of 0.540 in overall prediction performance. For cases with low proliferation (Ki-67

Key words: Breast cancer, Ki-67, Artificial Intelligence, Deep Learning, Artificial Neural Network







Bibliomed Article Statistics

25
12
R
E
A
D
S

17

6
D
O
W
N
L
O
A
D
S
0102
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.